GlassScriptPhysician profile
Hannah King
NPI 1134897283
$4,017.43
in general payments reported to CMS, 2019-2025
36 companies · $933 in 2025
The $933 reported for 2025 was more than what 82% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $624 · 2023: $1,363 · 2024: $1,098 · 2025: $933.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,394.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,393.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $722.78 | 2022-2025 | |
| Novo Nordisk INC | $586.32 | 2022-2025 | Wegovy, Ozempic |
| Lilly USA, LLC | $415.01 | 2022-2025 | Zepbound, Mounjaro, Jardiance |
| Amgen INC. | $293.42 | 2022-2025 | Repatha, Otezla, Evenity |
| Corium, LLC | $235.07 | 2022-2025 | Azstarys |
| Astellas Pharma US INC | $201.59 | 2024-2025 | Veozah |
| Pfizer INC. | $192.70 | 2023-2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $173.13 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $170.69 | 2022-2025 | Breztri, Airsupra |
| Glaxosmithkline, LLC. | $126.35 | 2023-2024 | Trelegy Ellipta, Shingrix, Arexvy |
| Exact Sciences Corporation | $98.84 | 2023-2025 | Cologuard Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $92.67 | 2022-2023 | Jardiance |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $81.66 | 2023-2025 | Xifaxan |
| Gilead Sciences, INC. | $63.71 | 2023-2025 | |
| Dynavax Technologies Corporation | $49.73 | 2023-2024 | Heplisav-B |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $41.63 | 2022-2023 | Rotateq, M-M-R II, Gardasil 9 |
| Bayer Healthcare Pharmaceuticals INC. | $41.42 | 2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $39.62 | 2023-2025 | Caplyta |
| Hologic Sales and Service, LLC | $33.34 | 2022-2023 | Coolseal Generator |
| Takeda Pharmaceuticals U.S.A., INC. | $30.56 | 2023 | Trintellix |
| Halozyme INC | $30.15 | 2023 | |
| Cranial Technologies, INC | $28.84 | 2023-2024 | Doc Band |
| Alkermes, INC. | $26.43 | 2024 | Vivitrol |
| Kowa Pharmaceuticals America, INC. | $26.31 | 2023 | Seglentis, Livalo |
| Mayne Pharma Commercial LLC | $24.44 | 2024-2025 | |
| Azurity Pharmaceuticals, INC. | $21.98 | 2025 | Horizant |
| Collegium Pharmaceutical, INC. | $21.33 | 2025 | Jornay Pm |
| Sanofi Pasteur INC. | $20.60 | 2023 | |
| Viiv Healthcare Company | $20.52 | 2024 | Apretude |
| Dexcom, INC. | $17.97 | 2024 | Dexcom G6 Transmitter |
| Verity Pharmaceuticals INC. | $17.93 | 2024 | Tlando |
| Verona Pharma, INC. | $15.27 | 2025 | Ohtuvayre |
| Tris Pharma INC | $14.66 | 2023 | Dyanavel Xr |
| Supernus Pharmaceuticals, INC. | $14.33 | 2023 | Tlando, Xyosted, Qelbree |
| Sanofi-Aventis U.S. LLC | $13.32 | 2022 | |
| Antares Pharma, INC. | $13.11 | 2024 | Xyosted |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hannah King listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.